The global orthopedic space has seen significant transformative changes in recent times. Major players like Stryker (SYK) and Zimmer Biomet (ZBH) have rapidly adopted differentiated strategies to make up for the lost growth during the pandemic. Both these S&P 500 players, who have started their 2024 journey on an optimistic note, are due to report first- quarter 2024 results in the upcoming week. Accordingly, it’s time for investors to revisit their quarter’s takeaway and assess the overall growth potential ...